View in EDS

Le traitement par bimekizumab a été efficace à 2 ans, quelle que soit la durée des symptômes de l'axSpA : résultats de deux essais de phase III.

Saved in:
Bibliographic Details
Title: Le traitement par bimekizumab a été efficace à 2 ans, quelle que soit la durée des symptômes de l'axSpA : résultats de deux essais de phase III.
Authors: Ramiro, S.1, Proft, F.2, Sengupta, R.3, Van Tubergen, A.4, Molto, A.1,5 sofiaramiro@gmail.com, Gensler, L.S.6, Kishimoto, M.7, Taieb, V.8, Voiniciuc, D.9, Massow, U.10, Navarro-Compán, V.11
Source: Revue du Rhumatisme. Dec2024, Vol. 91 Issue 6, pA206-A208. 3p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 181158833
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Le traitement par bimekizumab a été efficace à 2 ans, quelle que soit la durée des symptômes de l'axSpA : résultats de deux essais de phase III.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Ramiro%2C+S%2E%22">Ramiro, S.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Proft%2C+F%2E%22">Proft, F.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Sengupta%2C+R%2E%22">Sengupta, R.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Van+Tubergen%2C+A%2E%22">Van Tubergen, A.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Molto%2C+A%2E%22">Molto, A.</searchLink><relatesTo>1,5</relatesTo><i> sofiaramiro@gmail.com</i><br /><searchLink fieldCode="AR" term="%22Gensler%2C+L%2ES%2E%22">Gensler, L.S.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Kishimoto%2C+M%2E%22">Kishimoto, M.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Taieb%2C+V%2E%22">Taieb, V.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Voiniciuc%2C+D%2E%22">Voiniciuc, D.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Massow%2C+U%2E%22">Massow, U.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Navarro-Compán%2C+V%2E%22">Navarro-Compán, V.</searchLink><relatesTo>11</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Revue+du+Rhumatisme%22">Revue du Rhumatisme</searchLink>. Dec2024, Vol. 91 Issue 6, pA206-A208. 3p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=181158833
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.rhum.2024.10.067
    Languages:
      – Code: fre
        Text: French
    PhysicalDescription:
      Pagination:
        PageCount: 3
        StartPage: A206
    Titles:
      – TitleFull: Le traitement par bimekizumab a été efficace à 2 ans, quelle que soit la durée des symptômes de l'axSpA : résultats de deux essais de phase III.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ramiro, S.
      – PersonEntity:
          Name:
            NameFull: Proft, F.
      – PersonEntity:
          Name:
            NameFull: Sengupta, R.
      – PersonEntity:
          Name:
            NameFull: Van Tubergen, A.
      – PersonEntity:
          Name:
            NameFull: Molto, A.
      – PersonEntity:
          Name:
            NameFull: Gensler, L.S.
      – PersonEntity:
          Name:
            NameFull: Kishimoto, M.
      – PersonEntity:
          Name:
            NameFull: Taieb, V.
      – PersonEntity:
          Name:
            NameFull: Voiniciuc, D.
      – PersonEntity:
          Name:
            NameFull: Massow, U.
      – PersonEntity:
          Name:
            NameFull: Navarro-Compán, V.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 11698330
          Numbering:
            – Type: volume
              Value: 91
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Revue du Rhumatisme
              Type: main
ResultId 1